MLchartDataset catalogue

Atrasentan

Term · Oncology and biomedicine · MLC-T-ONC-000793

A substance that is being studied in the treatment of cancer. It belongs to the family of drugs called endothelin-1 protein receptor antagonists.

Table 1. Record
IdentifierMLC-T-ONC-000793
FieldOncology and biomedicine
ReferencesNCI Dictionary of Cancer Terms
Record as JSON 
{
  "id": "MLC-T-ONC-000793",
  "term": "Atrasentan",
  "field": "Oncology and biomedicine",
  "definition": "A substance that is being studied in the treatment of cancer. It belongs to the family of drugs called endothelin-1 protein receptor antagonists.",
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/atrasentan/"
}

Record 2,571 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.